Lincoln, NE, United States of America

Thomas E Clemente

USPTO Granted Patents = 1 

 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Thomas E. Clemente

Introduction

Thomas E. Clemente is a notable inventor based in Lincoln, Nebraska. He has made significant contributions to the field of biotechnology, particularly in the area of polyhydroxyalkanoate (PHA) production. His work has implications for sustainable materials and bioplastics, showcasing the intersection of science and environmental stewardship.

Latest Patents

Clemente holds a patent for "Rhodospirillum rubrum poly-.beta.-hydroxyalkanoate synthase." This patent involves isolated DNA fragments encoding a Rhodospirillum rubrum (ATCC 25903) polyhydroxyalkanoate synthase, along with biologically functional equivalents. The deduced amino acid sequence of the R. rubrum PHA synthase is also provided. These molecules are instrumental in the production of PHAs in both bacteria and plants, highlighting their potential for biotechnological applications.

Career Highlights

Clemente is associated with Monsanto Company, where he has been able to apply his expertise in genetic engineering and biotechnology. His work at Monsanto has allowed him to contribute to advancements in agricultural biotechnology, focusing on sustainable practices and innovative solutions.

Collaborations

Clemente has collaborated with notable colleagues such as Ganesh M. Kishore and Timothy A. Mitsky. These collaborations have fostered a productive environment for research and development, leading to significant advancements in their respective fields.

Conclusion

Thomas E. Clemente's contributions to biotechnology and his innovative patent on PHA synthase exemplify the importance of research in sustainable materials. His work continues to influence the field and promote environmentally friendly practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…